Stay updated on Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    A new NIH funding note 2015 ( U.S. NIH Grant/Contract ) was added to the study identifiers, and the page revision has been updated to v3.6.6, replacing the prior v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:04.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.4 to v3.6.5, signaling a small metadata update to the study record page. This change does not alter the study data or visible content.
    Difference
    0.0%
    Check dated 2026-08-08T17:15:36.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page's content or underlying code. This update is administrative and does not change study information or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-25T10:20:36.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.2 to v3.6.3, indicating a small update to the page's underlying revision history.
    Difference
    0.0%
    Check dated 2026-07-03T22:34:46.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2. This reflects an internal site update and does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-27T00:17:28.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating enrollment has ended. New navigation/help items were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the page updates the Intervention/Treatment header and revision label to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T15:35:38.000Z thumbnail image

Stay in the know with updates to Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib in HR+, HER2+ Breast Cancer Clinical Trial page.